Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024

Stocks that traded heavily or had substantial price changes on Friday: Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall

DBX : 23.13 (-0.04%)
PGNY : 27.53 (-15.29%)
NTRA : 105.29 (+10.19%)
MTD : 1,510.25 (+17.04%)
AKAM : 91.19 (-11.00%)
COLL : 31.50 (-16.80%)
Collegium Pharmaceutical: Q1 Earnings Snapshot

Collegium Pharmaceutical: Q1 Earnings Snapshot

COLL : 31.50 (-16.80%)
Collegium Pharmaceutical: Q4 Earnings Snapshot

Collegium Pharmaceutical: Q4 Earnings Snapshot

COLL : 31.50 (-16.80%)
Collegium Pharmaceutical: Q3 Earnings Snapshot

Collegium Pharmaceutical: Q3 Earnings Snapshot

COLL : 31.50 (-16.80%)
A Little Known Strategy Indicates These Three Companies Could Explode!

In this article, we look at price action strategies and uncover three companies with the potential for a breakout.

VSEC : 79.78 (-1.12%)
BAH : 156.06 (+1.11%)
COLL : 31.50 (-16.80%)
Collegium Pharmaceutical: Q2 Earnings Snapshot

Collegium Pharmaceutical: Q2 Earnings Snapshot

COLL : 31.50 (-16.80%)
Collegium Pharmaceutical (COLL) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Collegium Pharmaceutical (COLL) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with...

COLL : 31.50 (-16.80%)
Collegium Pharmaceutical (COLL) Q1 Earnings Meet Estimates

Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of 0% and 4.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

COLL : 31.50 (-16.80%)
XBIO : 3.90 (-3.62%)
Collegium Pharmaceutical: Q1 Earnings Snapshot

Collegium Pharmaceutical: Q1 Earnings Snapshot

COLL : 31.50 (-16.80%)
Pacira (PCRX) Lags Q1 Earnings Estimates

Pacira (PCRX) delivered earnings and revenue surprises of -11.67% and 2.12%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

PCRX : 29.42 (-1.47%)
COLL : 31.50 (-16.80%)

Barchart Exclusives

3 Dividend Kings That Cut (Or Will Cut) Their Dividends
Dividend aristocracy isn't always a sure thing. Here are 3 companies that have been or will be booted from the coveted king's list. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar